Antwerp University Hospital

Edegem, Antwerp B-2650

3 studies enrolling now · 8 studies all time

What they study most

Advanced Malignant Solid Tumor, Antifungal Agents, Calcium Release Deficiency Syndrome, Calcium Release Deficiency Syndrome (CRDS), Endometrial Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), Hepatic Impairment, Malignant Pleural Mesothelioma, Recurrent or Progressive Endometrial Cancer, Relapsed Small Cell Lung Cancer

Studies at this site

• International CRDS Registry — Recruiting now
• Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer — Recruiting now
• Evaluation of A Clinical Diagnostic Test for CRDS — Recruiting now
• Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed Small-cell Lung Cancer (LAGOON) — Completed
• INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC — Running, not enrolling
• A Study to Compare the Blood Levels and Safety of Tazemetostat in Participants With Advanced Cancer and Moderate/Severe Liver Impairment to Participants With Advanced Cancer and Normal Liver Function — Stopped early
• NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed — Completed
• Screening Anti-Fungal Exposure in Intensive Care Units — Status unconfirmed